Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02316288
Other study ID # 1R21AT007939-01A1
Secondary ID
Status Completed
Phase N/A
First received December 4, 2014
Last updated May 11, 2017
Start date December 2014
Est. completion date May 2017

Study information

Verified date May 2017
Source Wayne State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic pain is a costly public health problem that is associated with poor quality of life. Previous research has demonstrated extensive evidence showing that pain coping is not manifested by patients in isolation but within the context of significant relationships such as marriage. For instance, a partner may avoid or reject their partners' negative emotions about pain, provide unempathic responses to their partners' pain, or change their thoughts about pain. The patient's pain experience and the couples' relationship also have a cyclical relationship, in which both can affect each other and the overall quality of life for both partners. Currently, current clinical practice does not target both partners to alleviate pain. This is highly problematic given that a number of chronic pain patients—those with interpersonal distress—often do not complete, and thus, do not benefit fully from existing treatments. Even if treatment is completed, individuals may not maintain improvements if they return to distressed social environments that undermine individual coping efforts. Thus, it is clear that new interventions derived from integrative models of individual and dyadic coping are needed to alleviate pain and suffering in patients who are at risk for poor treatment outcomes. This research study aims to develop a novel psychological intervention aimed at couples in which one partner has chronic pain. Our central hypothesis is that a theoretically integrative intervention that improves both partners' psychological flexibility (i.e., acceptance, mindfulness, values-based action) and relational flexibility (i.e., emotional disclosure, empathic responding) skills will be feasible and valid and that it will alleviate pain and improve quality of life. This is a departure from current practice, which focuses solely on the patient's individual functioning, does not address the spouse's psychological inflexibility, and does not address relationship issues.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date May 2017
Est. primary completion date May 2017
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria:

- At least one spouse with some pain interference.

- Relationship dissatisfaction.

- Both partners at least 21 years old.

- Couples must also be married or cohabitating for at least 2 years regardless of sexual orientation to participate in the study.

Exclusion Criteria:

- Current suicidal or homicidal ideation or intent

- Current psychotic symptoms

- Cognitive impairment

- Malignancies (e.g., cancer) in either partner

- Current domestic violence

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness and Acceptance Therapy
Couples will learn psychological flexibility skills including mindfulness, acceptance, and values-based action as well as relational flexibility skills including empathic listening and responding during weekly 1.5-hour long sessions over the course of this 6-week intervention.
Health Education
Couples will learn about chronic pain including causes, consequences, and how to talk with their health care professionals about their pain during weekly 1.5-hour long sessions over the course of this 6-week program.

Locations

Country Name City State
United States Wayne State University Detroit Michigan

Sponsors (2)

Lead Sponsor Collaborator
Wayne State University National Center for Complementary and Integrative Health (NCCIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Treatment Credibility Credibility of Treatment Scale Baseline
Other Therapist Adherence audio recordings of sessions Participants will be followed for the duration of the intervention, an expected average of 6 weeks
Other Therapy Homework Compliance Homework Rating Scale and time spend completing homework Participants will be followed for the duration of the intervention, an expected average of 6 weeks
Other Therapy Session Satisfaction Participants' satisfaction with session Participants will be followed for the duration of the intervention, an expected average of 6 weeks
Other Intent to Complete Therapy Homework Participants' intention to complete homework Participants will be followed for the duration of the intervention, an expected average of 6 weeks
Other Adverse Events Adverse event data will be collected and reported Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Primary Change in Depressive Symptoms from Baseline to 1-month Followup Beck Depression Inventory-II Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Primary Change in Pain Intensity Visual Rating Scale, Multidimensional Pain Inventory, Brief Pain Inventory Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Primary Change in Pain Quality McGill Pain Questionnaire Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Primary Change in Quality of Life Satisfaction with Life Scale Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Primary Change in Relationship Satisfaction Dyadic Adjustment Scale; Dyadic Adjustment Scale-7 Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Primary Change in Sleep Quality PROMIS Sleep Disturbance and Sleep-related Impairment Scales Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Primary Change in Perceived Improvement Patient Global Impression of Change Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Secondary Change in Acceptance of Chronic Pain Chronic Pain Acceptance Questionnaire (baseline, post-treatment, followup); Chronic Pain Acceptance Chronic Pain Acceptance Questionnaire Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Secondary Change in Anxiety and Catastrophizing about Pain Pain Anxiety Symptoms Scale, Pain Catastrophizing Scale (baseline, post-treatment, followup); Pain Catastrophizing Scale-Shortened Version (weekly) Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Secondary Change in Mindfulness Five Facet Mindfulness Scale Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Secondary Change in Values-Based Action Chronic Pain Values Inventory Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Secondary Change in Dispositional Empathy Interpersonal Reactivity Index Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Secondary Change in Emotional Expression Ambivalence Over Emotional Expression Questionnaire, Holding Back Scale Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Secondary Change in Emotional Validation and Invalidation Coded from Couple Discussion Task Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
Secondary Change in Partner-perceived Empathy Perceived Partner Responsiveness Scale Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain